Different sources of oxidant stress in the early and late stage of atrial fibrillation by Reilly, SN, Alp, N, Casadei, B

Time-dependent regional differences in sources of oxidative stress in atrial fibrillation-induced remodelling by Reilly, SN, Schotten, U, Alp, N, Casadei, B

Molecular mechanisms underlying the myocardial nitric oxide-redox imbalance in human atrial fibrillation by Reilly, SN, Channon, K, Alp, N, Casadei, B

Dilated cardiomyopathy mutations in thin-filament regulatory proteins reduce contractility, suppress systolic Ca²⁺, and activate NFAT and Akt signaling by Robinson, P, Sparrow, AJ, Patel, S, Malinowska, M, Reilly, SN, Zhang, YH, Casadei, B, Watkins, H, Redwood, C

Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. by Reilly, SN, Jayaram, R, Nahar, K, Antoniades, C, Verheule, S, Channon, K, Alp, N, Schotten, U, Casadei, B

Atrial-specific LKB1 knockdown represents a novel mouse model of atrial cardiomyopathy with spontaneous atrial fibrillation by Hulsurkar, MM, Lahiri, SK, Moore, O, Moreira, LM, Abu-Taha, I, Kamler, M, Dobrev, D, Nattel, S, Reilly, SN, Wehrens, XHT